Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy

NCT: NCT07564102 · NOT_YET_RECRUITING

NCT IDNCT07564102
StatusNOT_YET_RECRUITING
Start Date2026-08-01
Completion2028-06-30

Brief Summary

The purpose of this study is to conduct a US Pilot study of dMD-002 as a peripheral nerve repair sheet in patients with cavernous nerve injury following radical prostatectomy. The study will determine which endpoints and timepoints will be used for the pivotal study.

Frequently Asked Questions

What is dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy?

dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy is a clinical trial registered under NCT07564102. Current status: NOT_YET_RECRUITING.

What is the status of NCT07564102?

The current status of NCT07564102 (dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy) is: NOT_YET_RECRUITING.

When did dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy start?

dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy started on 2026-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑